These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 32983141)
1. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection. Pal A; Gowdy KM; Oestreich KJ; Beck M; Shaikh SR Front Immunol; 2020; 11():1997. PubMed ID: 32983141 [TBL] [Abstract][Full Text] [Related]
2. Specialized pro-resolving mediator network: an update on production and actions. Chiang N; Serhan CN Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825 [TBL] [Abstract][Full Text] [Related]
3. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19. Rogero MM; Leão MC; Santana TM; Pimentel MVMB; Carlini GCG; da Silveira TFF; Gonçalves RC; Castro IA Free Radic Biol Med; 2020 Aug; 156():190-199. PubMed ID: 32653511 [TBL] [Abstract][Full Text] [Related]
4. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition. Serhan CN; Libreros S; Nshimiyimana R Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568 [TBL] [Abstract][Full Text] [Related]
5. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators. Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803 [TBL] [Abstract][Full Text] [Related]
7. Can Bioactive Lipids Inactivate Coronavirus (COVID-19)? Das UN Arch Med Res; 2020 Apr; 51(3):282-286. PubMed ID: 32229155 [TBL] [Abstract][Full Text] [Related]
8. The need for precision nutrition, genetic variation and resolution in Covid-19 patients. Simopoulos AP; Serhan CN; Bazinet RP Mol Aspects Med; 2021 Feb; 77():100943. PubMed ID: 33551236 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 and cancer: start the resolution! Barksdale C; Kipper FC; Tripathy S; Subbian S; Serhan CN; Panigrahy D Cancer Metastasis Rev; 2022 Mar; 41(1):1-15. PubMed ID: 35190921 [TBL] [Abstract][Full Text] [Related]
10. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection. Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665 [TBL] [Abstract][Full Text] [Related]
11. Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm. Lee CH Arch Pharm Res; 2021 Jan; 44(1):84-98. PubMed ID: 33398691 [TBL] [Abstract][Full Text] [Related]
12. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection. Huizinga GP; Singer BH; Singer K Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654 [TBL] [Abstract][Full Text] [Related]
13. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19. El-Missiry MA; El-Missiry ZMA; Othman AI Eur J Pharmacol; 2020 Sep; 882():173329. PubMed ID: 32615182 [TBL] [Abstract][Full Text] [Related]
14. Specialized proresolving mediators in infection and lung injury. Sandhaus S; Swick AG Biofactors; 2021 Jan; 47(1):6-18. PubMed ID: 33249673 [TBL] [Abstract][Full Text] [Related]
15. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity. Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087 [TBL] [Abstract][Full Text] [Related]
16. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome. Kwon Y Mol Nutr Food Res; 2020 Feb; 64(4):e1900824. PubMed ID: 31797565 [TBL] [Abstract][Full Text] [Related]
17. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity. Pasquarelli-do-Nascimento G; Braz-de-Melo HA; Faria SS; Santos IO; Kobinger GP; Magalhães KG Front Endocrinol (Lausanne); 2020; 11():530. PubMed ID: 32849309 [TBL] [Abstract][Full Text] [Related]
18. Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition. Al-Shaer AE; Buddenbaum N; Shaikh SR Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jul; 1866(7):158936. PubMed ID: 33794384 [TBL] [Abstract][Full Text] [Related]
19. Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation. Ferreira I; Falcato F; Bandarra N; Rauter AP Molecules; 2022 Mar; 27(5):. PubMed ID: 35268778 [TBL] [Abstract][Full Text] [Related]
20. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19. Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]